ARTICLE | Clinical News
Antagonist G peptide: PTD began a Phase I Australian trial with Antagonist G
April 22, 1996 7:00 AM UTC
Peptide Technology Ltd. (Aus: PTD), Dee Why, Australia Product: Antagonist G peptide Indication: Cancer Status: PTD began a 20-patient Phase I Australian trial with Antagonist G, a second-generation d...